Cadila Healthcare logo

CADILAHC - Cadila Healthcare Share Price

₹489.95 -9.8  -2.0%

Last Trade - 13/04/21

Large Cap
Market Cap £4.85bn
Enterprise Value £5.32bn
Revenue £1.45bn
Position in Universe 80th / 3106
Unlock CADILAHC Revenue
Relative Strength (%)
1m +13.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -7.90%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
86,513 96,170 95,723 119,544 131,656 142,531 150,923 164,812 +10.5%
+40.8 +67.6 -23.1 +21.1 +2.7 -20.5 +34.7 +6.99
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, CadilaHealthcare Ltd revenues increased 7% to RS112.56B. Netincome increased 85% to RS14.55B. Revenues reflectPharmaceuticals segment increase of 8% to RS99.95B. Netincome benefited from Finance Costs decrease of 46% toRS1.4B (expense), Other expenses decrease of 2% to RS30.24B(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from RS7.67 to RS14.21.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CADILAHC
Graphical History


CADILAHC Revenue Unlock CADILAHC Revenue

Net Income

CADILAHC Net Income Unlock CADILAHC Revenue

Normalised EPS

CADILAHC Normalised EPS Unlock CADILAHC Revenue

PE Ratio Range

CADILAHC PE Ratio Range Unlock CADILAHC Revenue

Dividend Yield Range

CADILAHC Dividend Yield Range Unlock CADILAHC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CADILAHC EPS Forecasts Unlock CADILAHC Revenue
Profile Summary

Cadila Healthcare Limited is an India-based pharmaceutical company. The Company's subsidiaries include Zydus Wellness Limited, Windlas Healthcare Pvt Ltd, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited, German Remedies Limited, Dialforhealth India Limited, Dialforhealth Unity Limited and Dialforhealth Greencross Limited, among others.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated May 15, 1995
Public Since May 15, 1995
No. of Shareholders: 130,106
No. of Employees: 13,405
Sector Healthcare
Industry Pharmaceuticals
Exchange National Stock Exchange of India
Shares in Issue 1,023,742,600
Free Float (0.0%)
Eligible for
CADILAHC Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CADILAHC
Upcoming Events for CADILAHC
Monday 24th May, 2021 Estimate
Q4 2021 Cadila Healthcare Ltd Earnings Release
Tuesday 3rd August, 2021 Estimate
Q1 2022 Cadila Healthcare Ltd Earnings Release
Friday 27th August, 2021 Estimate
Cadila Healthcare Ltd Annual Shareholders Meeting
Frequently Asked Questions for Cadila Healthcare
What is the Cadila Healthcare share price?

As of 13/04/21, shares in Cadila Healthcare are trading at ₹489.95, giving the company a market capitalisation of ¬£4.85bn. This share price information is delayed by 15 minutes.

How has the Cadila Healthcare share price performed this year?

Shares in Cadila Healthcare are currently trading at ₹489.95 and the price has moved by 38.5% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cadila Healthcare price has moved by -14.5% over the past year.

What are the analyst and broker recommendations for Cadila Healthcare?

Of the analysts with advisory recommendations for Cadila Healthcare, there are there are currently 10 "buy" , 6 "hold" and 3 "sell" recommendations. The overall consensus recommendation for Cadila Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Cadila Healthcare next release its financial results?

Cadila Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Cadila Healthcare dividend yield?

The Cadila Healthcare dividend yield is 0.71% based on the trailing twelve month period.

Does Cadila Healthcare pay a dividend?

Last year, Cadila Healthcare paid a total dividend of 3.5, and it currently has a trailing dividend yield of 0.71%. Looking ahead, Cadila Healthcare has not announced an ex-dividend date yet.

When does Cadila Healthcare next pay dividends?

Cadila Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on Cadila Healthcare shares is currently 0.71%.

How do I buy Cadila Healthcare shares?

To buy shares in Cadila Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cadila Healthcare?

Shares in Cadila Healthcare are currently trading at ₹489.95, giving the company a market capitalisation of ¬£4.85bn.

Where are Cadila Healthcare shares listed? Where are Cadila Healthcare shares listed?

Here are the trading details for Cadila Healthcare:

Country of listing: India
Exchange: NSI
Ticker Symbol: CADILAHC
What kind of share is Cadila Healthcare?

Based on an overall assessment of its quality, value and momentum, Cadila Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cadila Healthcare share price forecast 2021?

Shares in Cadila Healthcare are currently priced at ₹489.95. At that level they are trading at 1.11% discount to the analyst consensus target price of 0.00.

Analysts covering Cadila Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 19.393 for the next financial year.

How can I tell whether the Cadila Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cadila Healthcare. Over the past six months, the relative strength of its shares against the market has been -5.23%. At the current price of ₹489.95, shares in Cadila Healthcare are trading at 14.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cadila Healthcare PE Ratio?

The Cadila Healthcare PE ratio based on its reported earnings over the past 12 months is 24.79. The shares are currently trading at ₹489.95.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Cadila Healthcare?

Cadila Healthcare's management team is headed by:

Pankaj Patel - NEC
Mukesh Patel - NED
Sharvil Patel - MDR
Apurva Diwanji - NID
Nitin Parekh - CFO
Nitin Desai - NID
Dharmishtaben Raval - NID
Ganesh Nayak - EDR
Dhaval Soni - CCO
Who are the major shareholders of Cadila Healthcare?

Here are the top five shareholders of Cadila Healthcare based on the size of their shareholding:

Zydus Family Trust Corporation
Percentage owned: 74.86% (766.4m shares)
Life Insurance Corporation of India Insurance Company
Percentage owned: 2.36% (24.2m shares)
Kotak Mahindra Asset Management Company Ltd. Investment Advisor
Percentage owned: 2.25% (23.0m shares)
Kotak Standard Multicap Fund Mutual Fund
Percentage owned: 1.22% (12.5m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.18% (12.1m shares)
Similar to CADILAHC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.